These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25218594)

  • 1. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK
    Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice.
    Kubota M; Shimizu M; Sakai H; Yasuda Y; Terakura D; Baba A; Ohno T; Tsurumi H; Tanaka T; Moriwaki H
    Nutr Cancer; 2012; 64(1):72-9. PubMed ID: 22172229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.
    Kochi T; Shimizu M; Sumi T; Kubota M; Shirakami Y; Tanaka T; Moriwaki H
    BMC Gastroenterol; 2014 Dec; 14():212. PubMed ID: 25515685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Kubota M; Shimizu M; Sakai H; Yasuda Y; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
    Biochem Biophys Res Commun; 2011 Jun; 410(1):108-13. PubMed ID: 21640075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice.
    Fukuta K; Shirakami Y; Maruta A; Obara K; Iritani S; Nakamura N; Kochi T; Kubota M; Sakai H; Tanaka T; Shimizu M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
    Saxena A; Tammali R; Ramana KV; Srivastava SK
    Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
    Kato J; Shirakami Y; Mizutani T; Kubota M; Sakai H; Ibuka T; Shimizu M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.
    Shukla K; Sonowal H; Saxena A; Ramana KV; Srivastava SK
    Cancer Lett; 2017 Dec; 411():57-63. PubMed ID: 28986187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation.
    Tammali R; Reddy AB; Ramana KV; Petrash JM; Srivastava SK
    Carcinogenesis; 2009 May; 30(5):799-807. PubMed ID: 19028703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H
    Carcinogenesis; 2004 May; 25(5):821-5. PubMed ID: 14729596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
    Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
    Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Miyamoto S; Yasui Y; Ohigashi H; Tanaka T; Murakami A
    Chem Biol Interact; 2010 Jan; 183(2):276-83. PubMed ID: 19914226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis.
    Sonowal H; Saxena A; Qiu S; Srivastava S; Ramana KV
    Eur J Pharmacol; 2021 Mar; 895():173884. PubMed ID: 33482179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
    Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
    Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
    Saxena A; Shoeb M; Ramana KV; Srivastava SK
    Eur J Cancer; 2013 Oct; 49(15):3311-9. PubMed ID: 23827854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.